CereVasc announced today that it completed the first treatment with its eShunt system for treating communicating hydrocephalus (CH). Boston-based CereVasc touts the eShunt as the first minimally invasive cerebrospinal fluid shunt and delivery technology designed to avoid the need for invasive surgery and extended hospitalization associated with … [Read more...] about CereVasc successfully performs first-in-human procedure with eShunt system
CardioMech reports first in-person procedure with its transcatheter mitral valve repair tech
CardioMech confirmed the completion of the first procedure with its transcatheter mitral valve repair (TMVR) technology. At the Sanger Heart & Vascular Institute in North Carolina, a multidisciplinary heart team evaluated a patient diagnosed with severe symptomatic degenerative mitral regurgitation (DMR). They offered the patient a choice: … [Read more...] about CardioMech reports first in-person procedure with its transcatheter mitral valve repair tech
Caldera launches new Desara TVez for stress urinary incontinence
Surgical product developer Caldera Medical announced today that it launched the Desara TVez as part of its Desara portfolio. Los Angeles-based Caldera’s Desara family of products includes offerings for treating stress urinary incontinence, pelvic organ prolapse and polyps. Get the full story on our sister site, MassDevice. … [Read more...] about Caldera launches new Desara TVez for stress urinary incontinence
BD acquires Venclose and its RF ablation technology
BD (NYSE:BDX) announced today that it acquired Venclose and its solutions for treating chronic venous insufficiency (CVI). CVI occurs as the result of malfunctioning valves and can lead to varicose veins. Venclose’s CVI treatment uses radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain and … [Read more...] about BD acquires Venclose and its RF ablation technology
Teleflex recalls some Arrow-Trerotola over-the-wire PTD kits
Teleflex (NYSE:TFX) announced that it initiated a worldwide recall of its Arrow-Trerotola over-the-wire PTD (percutaneous thrombolytic device) kit. Wayne, Pennsylvania-based Teleflex designed the Arrow-Trerotola (PTD) catheter in conjunction with the Arrow rotator drive unit to allow for the mechanical declotting of the native arterio-venous … [Read more...] about Teleflex recalls some Arrow-Trerotola over-the-wire PTD kits
ALung Technologies wins FDA de novo nod for Hemolung respiratory assist system
ALung Technologies announced today that it received FDA de novo clearance for its Hemolung respiratory support platform. Pittsburgh-based ALung designed its Hemolung system to provide low-flow extracorporeal carbon dioxide removal (ECCO2R) for patients with acute respiratory failure. Get the full story at our sister site, MassDevice. … [Read more...] about ALung Technologies wins FDA de novo nod for Hemolung respiratory assist system
Medtronic reports promising early data for transfemoral delivery of its Intrepid TMVR
Medtronic (NYSE:MDT) this week touted data for its Intrepid self-expanding transcatheter mitral valve replacement (TMVR) system. Early data from 15 patients in an early feasibility study was presented as late-breaking clinical science at the 33rd Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the … [Read more...] about Medtronic reports promising early data for transfemoral delivery of its Intrepid TMVR
Edwards touts trial results for Evoque transcatheter tricuspid valve replacement system
Edwards Lifesciences (NYSE:EW) shared data from a clinical trial showing that its Evoque transcatheter tricuspid valve replacement offers favorable patient outcomes. Irvine, California–based Edwards presented the data during the late-breaking clinical science session at the 33rd Transcatheter Cardiovascular Therapeutics (TCT), according to a … [Read more...] about Edwards touts trial results for Evoque transcatheter tricuspid valve replacement system
Alcon to acquire Ivantis for $475M
Alcon (NYSE:ALC) announced today that it intends to acquire glaucoma surgery device maker Ivantis for $475 million upfront. Geneva, Switzerland-based Alcon aims to bolster its portfolio across cataract, refractive, retina and glaucoma offerings by acquiring Ivantis and its novel Hydrus Microstent for minimally invasive glaucoma surgery … [Read more...] about Alcon to acquire Ivantis for $475M
Data shows safety and strong performance for Penumbra’s Indigo CAT RX catheter
Penumbra (NYSE:PEN) announced today that the Cheetah clinical study for its Indigo CAT RX catheter met its primary endpoint. Alameda, California-based Penumbra’s Indigo catheter system demonstrated high rates of blood clot removal, blood flow restoration and myocardial perfusion in conjunction with percutaneous coronary intervention (PCI) in … [Read more...] about Data shows safety and strong performance for Penumbra’s Indigo CAT RX catheter
